Why Diamond Jewelry Retailer Signet’s Shares Are Gaining Today

Signet Jewelers Ltd (NYSE: SIG) shares are trading higher by around 4% after it reported Q3 FY24 results. Sales declined 12.1% YY to $1.392 billion, marginally beating the analyst consensus of $1.390 billion.

Signet Jewelers Ltd (NYSE:SIG) shares are trading higher by around 4% after it reported Q3 FY24 results. Sales declined 12.1% YY to $1.392 billion, marginally beating the analyst consensus of $1.390 billion. Same-store sales were down 11.8% versus last year.

North America segment sales amounted to $1.3 billion, an 11.9% decrease Y/Y. Same-store sales for the segment decreased 12.3% versus last year. International segment same-store sales decreased 4.6%, and sales fell 1.4% Y/Y to $94.0 million.

Gross margin of 36.0%, up 110 basis points Y/Y. The operating income for the quarter was $13.3 million versus $48.4 million last year, with an operating margin of 1.0%.

Adjusted EPS of $0.24 beat the analyst consensus estimate of $1.18. 

“Trends through Black Friday weekend, including sequential improvement in engagement trends, are performing in line with guidance expectations for the fourth quarter. As we enter the holiday season, jewelry remains a top of mind gifting category for consumers in a value conscious shopping environment,” commented Virginia C. Drosos, CEO. 

Signet’s operating cash flow used year-to-date was $(205.3) million versus $(155.5) million in the prior year. It held cash and equivalents of $643.8 million as of October 28, 2023.

Inventory ended the quarter at $2.1 billion, approximately 14% below Q3 of FY23.

Related: Signet Jewelers’ Engagement Sales Set to Rebound In Q4: Analyst Asserts

Dividend: Signet’s Board declared a quarterly cash dividend of $0.23 per share, payable on February 23, 2024, to shareholders of record on January 26, 2024.

As of December 1, Signet has repurchased approximately 1.8 million shares for $128.5 million, including $35.1 million during the third quarter. It had shares around $672 million remaining under the multi-year authorization.

Guidance: Signet expects Q4 sales of $2.40 billion – $2.60 billion, versus the consensus of $2.55 billion.

SIG lowered the outlook for FY24 sales to $7.07 billion – $7.27 billion from $7.10 billion – $7.30 billion (vs. consensus of $7.22 billion).

Signet revised FY24 adjusted EPS outlook to $9.55-$10.18 from $9.55 – $10.14, against the Street view of $9.81.

“Cost savings initiatives are on track and healthy inventory enables product newness as we enter the holiday season and improved free cash flow, allowing Signet to return nearly $160 million to shareholders already this year,” said Joan Hilson, Chief Financial, Strategy & Services Officer.

Price Action: SIG shares are up 3.73% at $87.95 on the last check Tuesday.

Photo Via Company

Total
0
Shares
Related Posts
Read More

Medtronic Presented Late-Breaking Data Showing Performance Of Its OmniaSecure Defibrillation Lead Met Its Primary Safety And Effectiveness Endpoints, Exceeding Prespecified Performance Goals, In The Global LEADR Pivotal Trial

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart RhythmDUBLIN and BOSTON, May 17, 2024 /PRNewswire/ -- Medtronic plc

MDT